1. Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
- Author
-
Florian Krammer, Erna Milunka Kojic, Xiaomei Liu, Benhur Lee, Christian S. Stevens, Ian Baine, Fatima Amanat, Juan C. Bandres, Jonathan Stoever, Denise Jurczyszak, Gospel Enyindah-Asonye, Weiss S, Catarina E. Hioe, Sean T. H. Liu, Susan Zolla-Pazner, Simon, Jéromine Klingler, Arthur Nádas, Kasopefoluwa Y. Oguntuyo, Maria Bermudez-Gonzalez, Chuan-Tien Hung, Suzanne Arinsburg, and Satoshi Ikegame
- Subjects
Male ,Convalescent plasma ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Antibodies, Viral ,Neutralization ,Virus ,Article ,COVID-19 Testing ,Neutralization Tests ,Major Article ,Potency ,Humans ,Multiplex ,COVID-19 Serotherapy ,biology ,Chemistry ,SARS-CoV-2 ,Immunization, Passive ,COVID-19 ,neutralization ,Virology ,Antibodies, Neutralizing ,Immunoglobulin A ,Immunoglobulin Isotypes ,AcademicSubjects/MED00290 ,antibody isotypes ,Immunoglobulin M ,Immunoglobulin G ,convalescent plasma ,Spike Glycoprotein, Coronavirus ,biology.protein ,Female ,Antibody - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the spike protein. Although studies have demonstrated anti-spike and -RBD antibodies to be protective in animal models, and convalescent plasma as a promising therapeutic option, little is known about immunoglobulin isotypes capable of blocking infection.We studied spike- and RBD-specific immunoglobulin isotypes in convalescent and acute plasma/serum samples using a multiplex bead assay. We also determined virus neutralization activities in plasma and serum samples, and purified immunoglobulin fractions using a vesicular stomatitis pseudovirus assay.Spike- and RBD-specific immunoglobulin (Ig) M, IgG1, and IgA1 were produced by all or nearly all subjects at variable levels and detected early after infection. All samples displayed neutralizing activity. Regression analyses revealed that IgM and IgG1 contributed most to neutralization, consistent with IgM and IgG fractions' neutralization potency. IgA also exhibited neutralizing activity, but with lower potency.IgG, IgM, and IgA are critical components of convalescent plasma used for treatment of coronavirus disease 2019 (COVID-19).
- Published
- 2020